Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder.
about
Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Osteoblastic progression durin ...... g cancer: a potential blunder.
@en
Osteoblastic progression durin ...... g cancer: a potential blunder.
@nl
type
label
Osteoblastic progression durin ...... g cancer: a potential blunder.
@en
Osteoblastic progression durin ...... g cancer: a potential blunder.
@nl
prefLabel
Osteoblastic progression durin ...... g cancer: a potential blunder.
@en
Osteoblastic progression durin ...... g cancer: a potential blunder.
@nl
P2093
P50
P356
P1433
P1476
Osteoblastic progression durin ...... ng cancer: a potential blunder
@en
P2093
Beatrice Bortesi
Enrico Rabaiotti
Francesco Facchinetti
Paola Bini
Sebastiano Buti
P356
10.5301/TJ.5000423
P577
2015-09-19T00:00:00Z